Skip to content

RNA

Avidity Biosciences, Inc.

NASDAQ · Healthcare · Biotechnology · US

$7.61
−0.78%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
13.00x

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
0.61x
Price / sales
5.54x
Price / cash flow
-3.17x

Enterprise value

Enterprise value
-$132.4M
EV / sales
-5.63x
EV / EBITDA
1.39x
EV / EBIT
1.37x
Market cap
$130.2M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026